Sonoma Pharmaceuticals, Inc.
Hedge Funds Holdings

Last updated:

Sonoma Pharmaceuticals, Inc.‘s stocks are currently a part of 13 hedge funds’ portfolios, which represents 100% of the total amount of its stocks outstanding. This makes up a total of 84.37K shares of Sonoma Pharmaceuticals, Inc.. Compared to the previous quarter, the number fell by -40.76% or -58.06K shares fewer. As for the holding position changes, 7.69% (1) of current hedge fund investors increased the number of shares held, 7.69% (1) of current holders sold a part of the shares held, and 7.69% (1) closed the holdings completely. 4 hedge funds are new holders of Sonoma Pharmaceuticals, Inc. stock in Q1 2023, it is 30.77% of total holders.

Hedge funds holding Sonoma Pharmaceuticals (Q2 2018 – Q1 2023)

Number of hedge funds
Q2 2018 20
Q3 2018 21
Q4 2018 14
Q1 2019 18
Q2 2019 9
Q3 2019 8
Q4 2019 8
Q1 2020 8
Q2 2020 7
Q3 2020 12
Q4 2020 11
Q1 2021 11
Q2 2021 12
Q3 2021 11
Q4 2021 11
Q1 2022 10
Q2 2022 10
Q3 2022 9
Q4 2022 13
Q1 2023 13

Hedge funds changes in Sonoma Pharmaceuticals positions (Q2 2018 – Q1 2023)

Changes in positions
Q2 2018 35345
Q3 2018 43635
Q4 2018 34310-6
Q1 2019 73233
Q2 2019 90018-18
Q3 2019 11321
Q4 2019 13013
Q1 2020 22211
Q2 2020 12220
Q3 2020 62112
Q4 2020 11324
Q1 2021 24122
Q2 2021 32520
Q3 2021 33140
Q4 2021 22322
Q1 2022 12223
Q2 2022 22222
Q3 2022 02313
Q4 2022 7133-1
Q1 2023 41116

Top 50 hedge fund holders of Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA)

Hedge fund Value Shares owned Portfolio share
RENAISSANCE TECHNOLOGIES LLC Jim Simons 161K 75.36K 0.000%
GEODE CAPITAL MANAGEMENT, LLC 78K 36.87K 0.000%
VANGUARD GROUP INC 72K 34.01K 0.000%
CITADEL ADVISORS LLC Ken Griffin 39K 18.36K 0.000%
HBC FINANCIAL SERVICES, PLLC 17K 200 0.014%
UBS GROUP AG 12K 5.50K 0.000%
TOWER RESEARCH CAPITAL LLC (TRC) 10K 4.81K 0.000%
BLACKROCK INC. Larry Fink 6K 2.87K 0.000%
US BANCORP \DE\ 1K 500 0.000%
BANK OF AMERICA CORP /DE/ 0 0 0.000%